4.3 Article

Anti-tumor Study of Chondroitin Sulfate-Methotrexate Nanogels

Journal

NANOSCALE RESEARCH LETTERS
Volume 12, Issue -, Pages -

Publisher

SPRINGER
DOI: 10.1186/s11671-017-2324-1

Keywords

Methotrexate; Chondroitin sulfate; Self-assembly; Nanogels; Anti-tumor; Nanomedicine; Nanotechnology

Funding

  1. National Natural Science Foundation [81201364, 81328015]
  2. Science and Technology Department of Jiangsu Province [BE2017689]
  3. Priority Academic Program Development of Jiangsu Higher Education Institutions

Ask authors/readers for more resources

Self-assembly nanogels (NGs) were formed by bioconjugating methotrexate (MTX) with chondroitin sulfate (CS). MTX-CS NGs can greatly enhance the solubility and improve the delivery efficacy of MTX due to the CD44 binding property of CS. Vivo experiments revealed that MTX-CS NGs showed less toxicity than MTX. MTX-CS NGs can improve the anti-tumor effect while reducing the side effects of MTX. Due to their CD44 binding property, chondroitin sulfate-drug conjugates could be a promising and efficient platform for improving the solubility of sparingly soluble drug molecules as well as targeted delivery to cancer cells and tumor tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available